Genedrive Plc

LSE:GDR.L

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

🩺 Medical Instruments

💻 Telehealth

Location

United Kingdom

Market Cap

USD 12.08 M

Share Price

USD 0.02

Avg Daily Volume

6,362,967

Change (1 day)

-0.15%

Change (1 year)

-29.76%

Change (YTD)

-36.70%

Genedrive Plc Accounts Payable for the year ending July 11, 2025: N/A

Genedrive Plc Accounts Payable is NA for the year ending July 11, 2025. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.

Competitors

Roche Holding AG

USD 349.07

RO.SW

+1.94 0.56%

Abbott Laboratories

USD 133.60

ABT

+0.38 0.29%

Thermo Fisher Scientific Inc.

USD 430.73

TMO

+10.85 2.58%

Boston Scientific Corporation

USD 103.86

BSX

+0.90 0.87%

Siemens Healthineers AG

USD 55.98

SHL.DE

+0.43 0.78%

Becton, Dickinson and Company

USD 177.50

BDX

+2.00 1.14%

GE HealthCare Technologies Inc.

USD 76.50

GEHC

+0.99 1.31%

Agilent Technologies, Inc.

USD 124.17

+2.87 2.37%

Natera, Inc.

USD 163.36

NTRA

+1.61 1.00%

Laboratory Corporation of America Holdings

USD 253.63

-5.44 -2.10%

bioMérieux S.A.

USD 142.27

BIM.PA

+1.98 1.41%

Baxter International Inc.

USD 29.70

BAX

-0.11 -0.37%

Revvity, Inc.

USD 102.40

RVTY

+2.27 2.27%

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

USD 8.36

603392.SS

-0.05 -0.62%

Exact Sciences Corporation

USD 53.32

EXAS

-1.99 -3.60%

Qiagen N.V.

USD 48.55

QGEN

+0.59 1.23%

Tempus AI, Inc.

USD 59.60

TEM

+1.19 2.04%

Globus Medical, Inc.

USD 57.80

GMED

+0.49 0.85%

ConvaTec Group Plc

USD 3.58

CTEC.L

+0.01 0.15%

Hangzhou Tigermed Consulting Co., Ltd.

USD 6.26

3347.HK

+0.12 1.91%

Key Data

Date	Accounts Payable	Short-Term Debt	Long-Term Debt	Total Liabilities